UMIN-CTR Clinical Trial

Recruitment status Enrolling by invitation
Unique ID issued by UMIN UMIN000045249
Receipt No. R000049386
Scientific Title Research study for microsatellite instability in malignancy in hepato-biliary-pancreatic field (KHBO 1903-1-2)
Date of disclosure of the study information 2021/08/25
Last modified on 2021/08/24 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Research study for microsatellite instability in malignancy in hepato-biliary-pancreatic field (KHBO 1903-1-2)
Acronym MHBPKHBO1903-1-2
Scientific Title Research study for microsatellite instability in malignancy in hepato-biliary-pancreatic field (KHBO 1903-1-2)
Scientific Title:Acronym MHBPKHBO1903-1-2
Region
Japan

Condition
Condition Malignancy in hepato-biliary-pancreatic field
Classification by specialty
Hepato-biliary-pancreatic surgery
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 This study is aimed to investigate the proportion of high microsatellite instability in malignancy in hepato-biliary-pancreatic field and characteristic of patients with malignancy with high microsatellite instability for the appropriate treatment selection.
Basic objectives2 Others
Basic objectives -Others None
Trial characteristics_1 Confirmatory
Trial characteristics_2 Explanatory
Developmental phase Not applicable

Assessment
Primary outcomes The proportion of high microsatellite instability in malignancy in hepato-biliary-pancreatic field
Key secondary outcomes characteristic of patients with malignancy with high microsatellite instability

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
1 years-old <=
Age-upper limit
100 years-old >
Gender Male and Female
Key inclusion criteria Patients who underwent test for microsatellite instability between 2019 and 2022
Key exclusion criteria Patients who do not agree for this study
Target sample size 400

Research contact person
Name of lead principal investigator
1st name Shoji
Middle name
Last name Kubo
Organization Osaka City University
Division name Department of Hepato-Biliary-Pancreatic Surgery
Zip code 545-8585
Address 1-4-3 Asahimachi, Abeno-ku, Osaka
TEL 06-6645-3841
Email m7696493@msic.med.osaka-cu.ac.jp

Public contact
Name of contact person
1st name Shoji
Middle name
Last name Kubo
Organization Osaka City University
Division name Department of Hepato-Biliary-Pancreatic Surgery
Zip code 545-8585
Address 1-4-3 Asahimachi, Abeno-ku, Osaka
TEL 06-6645-3841
Homepage URL http://www.med.osaka-cu.ac.jp/ocum-surgery/abdomen/stuff.html
Email m7696493@msic.med.osaka-cu.ac.jp

Sponsor
Institute Department of Hepato-Biliary-Pancreatic Surgery, Osaka City University
Institute
Department

Funding Source
Organization Department of Hepato-Biliary-Pancreatic Surgery, Osaka City University
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization Japan

Other related organizations
Co-sponsor Kansai Hepato-Biliary Oncology Group
Name of secondary funder(s)

IRB Contact (For public release)
Organization Osaka City University
Address 1-2-7 Asahimachi, Abeno-ku, Osaka
Tel 06-6645-3456
Email ethics@med.osaka-cu.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 大阪国際がんセンター、京都大学、大阪大学、山口大学、兵庫医科大学、関西医科大学、国立病院機構大阪医療センター、大阪労災病院、関西電力病院、市立東大阪医療センター、ベルランド総合病院

Other administrative information
Date of disclosure of the study information
2021 Year 08 Month 25 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Enrolling by invitation
Date of protocol fixation
2020 Year 05 Month 19 Day
Date of IRB
2020 Year 07 Month 29 Day
Anticipated trial start date
2021 Year 03 Month 01 Day
Last follow-up date
2022 Year 03 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information Cohort study

Management information
Registered date
2021 Year 08 Month 24 Day
Last modified on
2021 Year 08 Month 24 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049386